InvestorsHub Logo
Followers 5
Posts 652
Boards Moderated 0
Alias Born 08/10/2018

Re: None

Wednesday, 04/08/2020 2:29:47 PM

Wednesday, April 08, 2020 2:29:47 PM

Post# of 233590

CytoDyn Collaborating with U.K. - Emergency Access to Leronlimab

CytoDyn Collaborating with U.K.’s Department of Health to Provide Emergency Access to Leronlimab for Severe and Critically Ill COVID-19 Patients

VANCOUVER, Washington, April 07, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that it is collaborating with the U.K.’s Department of Health to provide emergency access to leronlimab, the Company’s investigational medicine for COVID-19.


I am not an accountant. I’m just a retiree with a computer and an Internet connection. No part of this site’s content should be construed as advice, and you should not take anything that is said here as investment or financial advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News